SFO issues injection guidelines

Maintain fixed intervals and opt for same-day bilateral injections

SFO issues injection guidelines
Dermot McGrath
Dermot McGrath
Published: Friday, March 20, 2020
The French Society of Ophthalmology (SFO), through its president Prof Laurent Kodjikian, has issued specific guidelines to its members concerning the administration of intravitreal injections (IVI) in light of the COVID-19 epidemic. SFO recommends: In cases of neovascular AMD: maintain injections only, spacing patients over the course of the day and cancelling consultations (therefore no OCT controls) in order to avoid grouping of patients. For this, SFO advises keeping a fixed interval for injections (the minimal necessary to maintain efficacy) and to favour same-day bilateral injections where possible so the patient does not have to return twice to the clinic. Bear in mind that there are specific individual cases that will require the completion of an OCT scan for correct decision-making, in particular for the control of the second eye. In the case of new vessels linked to high myopia or inflammatory pathologies: The same strategy as above for nAMD can be applied for these patients. In case of diabetic macular oedema (DME) and macular oedema after retinal vein occlusion: A postponement does not generally jeopardise the functional prognosis and can be performed at a later stage in the vast majority of cases. Angiograms deemed necessary for decision-making and urgent laser treatments (such as pan-retinal photocoagulation for severe proliferative diabetic retinopathy) can be maintained, but only sparingly. The monitoring and treatment of proliferative and severe diabetic retinopathy should not be interrupted. Finally, SFO said it was vital to continue to treat ocular emergencies by all centres with the capability to do in terms of respecting the requisite sanitary controls for COVID-19 and to limit as much as possible non-emergency surgical and medical activity for all the population.
Tags: coronavirus, covid-19, covid19
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...